Sign In
Buy CHFS
$1.00
+0 (+0%)
At Close: Aug 17, 2022
CHF Solutions, Inc. Announces Registered Direct Offering Priced At-the-Market
05:40pm, Friday, 01'st May 2020
CHF Solutions (CHFS) today announced the pricing of a registered direct offering of 3,597,880 shares of its common stock at a price of $0.4725 per share, for gross proceeds of approximately $1.7 milli
CHF Solutions Ships Aquadex Product to COVID-19 Specialty Center in Minnesota
12:00pm, Friday, 01'st May 2020
EDEN PRAIRIE, Minn., May 01, 2020 -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today.
CHF Solutions Ships First Commercial Orders of Aquadex SmartFlow™ system to Austria
12:00pm, Thursday, 23'rd Apr 2020
EDEN PRAIRIE, Minn., April 23, 2020 -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today.
CHF Solutions Receives $1.66 Million under SBA’s Paycheck Protection Program and $1.1 Million from Warrant Exercises
12:00pm, Tuesday, 21'st Apr 2020
CHF Solutions (CHFS), a small and growing medical device company dedicated to changing the lives of patients suffering from fluid overload, announced receipt of $1.66 million under the Paycheck Protec
CHF Solutions Announces 300% Increase in Utilization of Aquadex Therapy in NYC Hospitals, the Epicenter of COVID-19
01:00pm, Thursday, 16'th Apr 2020
CHF Solutions (CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced increased utilization of its Aquadex therapy in patients affected by
CHF Solutions (CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced that physicians on the frontlines of treating patients with COVID-19
CHF Solutions Submits Patent Application for Hemofiltration System for Rapid Clearing of Cytokines in COVID-19 patients
12:00pm, Thursday, 09'th Apr 2020
CHF Solutions (CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for an adaptation to th
CHF Solutions Convene Physicians to Discuss Cardio-Pulmonary-Renal Management of COVID-19 Patients
01:15pm, Wednesday, 08'th Apr 2020
EDEN PRAIRIE, Minn., April 08, 2020 -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today.
CHF Solutions Doubles Production Staff of Aquadex SmartFlow™ Consoles Due to Hospital Demand
12:00pm, Thursday, 02'nd Apr 2020
CHF Solutions (CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced that it has doubled the production staff that builds its next genera
CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
01:26pm, Monday, 30'th Mar 2020
CHF Solutions (CHFS) today announced the pricing of a registered direct offering of 5,130,228 shares of its common stock at a price to the public of $0.434 per share, for gross proceeds of approximate
More Covid-19-related activity - healthcare
12:17pm, Wednesday, 25'th Mar 2020
CHF Solutions (NASDAQ:CHFS) announced the use of its Aquadex ultrafiltration therapy to treat volume overload in COVID-19 patients. Shares up 35% premarket.Endonovo Therapeutics (OTCQB:ENDV) has re
CHF Solutions Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management
12:00pm, Wednesday, 25'th Mar 2020
CHF Solutions (CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, announced the use of its Aquadex therapy in the treatment of patients infected
